- The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma
Chris Yang et al, 2019, Cancers CrossRef - Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma
Kazuki Tashiro et al, 2019, Odontology CrossRef - STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma via Inhibiting FoxO1
Min Zheng et al, 2019, Front. Oncol. CrossRef - Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
Qiang Li et al, 2020, Front. Oncol. CrossRef - MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3
Jinpeng Wang et al, 2020, Front. Immunol. CrossRef - STAT3 Mediated miR-30a-5p Inhibition Enhances Proliferation and Inhibits Apoptosis in Colorectal Cancer Cells
Chun-Chia Cheng et al, 2020, IJMS CrossRef - Palmitic Acid-Induced miR-429-3p Impairs Myoblast Differentiation by Downregulating CFL2
Mai Thi Nguyen et al, 2021, IJMS CrossRef - Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
Yanhong Ni et al, 2022, Front. Immunol. CrossRef - The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.
Gautam Sethi, 0 CrossRef - The Impact of STAT3 rs1053005 Variation on Type 1 Diabetes Mellitus Susceptibility: Association Study and in Silico Analysis
Maryam Zandi et al, 2022, Immunological Investigations CrossRef - STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma
Mingjing Jiang et al, 2022, Cells CrossRef - Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
Bedanta Bhattacharjee et al, 2023, Front. Pharmacol. CrossRef - Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma
Yuxi Cheng et al, 2024, Clin Epigenet CrossRef